Herpes simplex virus (HSV)-induced keratitis (HSK) occurs largely secondary to an immunologically driven inflammatory response to the viruS.1 -5 Although much is now known about systemic immunity and cytokine response to viral infection, little is known about the regional cytokine gene expression in the cornea following corneal inoculation with HSV.
The mechanisms of defence against HSV MARK HU, JAMES DUn, VICTOR ARRUNATEGUI-CORREA, STEFANOS BALTATZIS, C. STEPHEN FOSTER infection almost certainly involve not only the development of a systemic immune response to HSV but also the local secretion of cytokines with antiviral activity. Interleukin-l (IL-l), tumour necrosis factor ex (TNF-ex) and IL-6 are mainly produced by cells of monocyte lineage and are considered to be major mediators of inflammation. 6, 7 It is suggested that they may display a similar but not identical spectrum of activities including differentiation and growth regulating activities, inflammatory and anti inflammatory, haematopoietic, anti-tumoural and antiviral activities. However, their roles in inflammation, particularly in HSV-infected corneas, remain to be elucidated.
IL-l is widely regarded as a primary mediator of specific and non-specific inflammation, and transforming growth factor 13 (TGF-f3) is a well-known potent down-regulator of inflammatory reactions, inhibiting B-and T-cell proliferation, cytokine production and many cytokine-mediated immune responses. 8 The importance of TGF-f3 in controlling inflammatory responses is highlighted by the finding that mice with a targeted disruption of the TGF-f3 gene suffer from an acute wastage syndrome characterised by inflammatory cell infiltration and tissue necrosis.9 The roles of IL-6 and TNF-ex are not yet fully understood. Reports increasingly indicate that IL-6 and TNF-ex can be anti-inflammatory and immunosuppressive. 1 0-1 4 Some inbred strains of mice can tolerate HSV infection, with no clinically evident inflammation of the infected corneas, while others develop necrotising stromal keratitis after HSV corneal inoculation. Indeed this difference in HSK susceptibility resides in the fine specificity of gene loci at or near the Igh-l locus on chromosome 12.15 A novel anti inflammatory agent, tetrandrine, isolated from an ancient Chinese herbal remedy, is a potent inhibitor of the destructive inflammation typical of HSK in genetically susceptible mice;16 and acyclovir, of course, is also therapeutically beneficial for murine HSK. The objectives of the present study were to evaluate. and compare the difference in local cytokine gene expression between inflamed and non-inflamed corneas, and to examine the influence of tetrandrine and acyclovir on the expression of these cytokines in HSV-infected corneas.
Materials and methods

Virus
The HSV-1 (KOS strain) stock was obtained from Dr Priscilla Schaffer (Harvard Medical School, Boston), grown in our laboratory, and passed twice in Vero cell monolayers (American Type Culture Collection, ATCC, CCL 81, Rockville, MD), as previously described.I, 16 The same virus suspended in Eagle's Minimum Essential Medium (MEM) was used in all experiments.
Pharmacological agents
Tetrandrine (Aldrich Chemical Company, Milwaukee, WI), was used after conversion to the hydrochloride form, soluble in water. Acyclovir (Burroughs Wellcome, Research Triangle Park, NC) was freshly dissolved in distilled water as a 1.5% solution before injection.
Animals
Male BALB / C mice 6-8 weeks of age were obtained from The Jackson Laboratories (Bar Harbour, ME) and housed in microisolators mounted in ventilated animal racks in our facility. All animals were handled in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Corneal inoculation
Corneal infection of HSV-1 and treatment were performed as previously described.I,16 Briefly, mice were anaesthetised with 2 mg of intraperitoneal ketamine hydrochloride (Ketalar, Parke-Davis, Morris Plains, NJ) and 400 mg of xylazine (Rompun, Mobay, Shawnee, KD). The right cornea of each mouse was scratched eight times in a criss-cross pattern with a 25-gauge needle, and 5 ,.d of HSV-1 suspension containing 105 plaque-forming units was instilled in the cul-de-sac as previously described.I,16 Twenty mice infected with HSV -1 were injected intraperitoneally (i.p.) with distilled water and served as controls. The second group of 20 infected mice were injected (i.p.) with acyclovir 60 mg/kg twice daily from day 0, and the third group of 20 infected mice were injected with tetrandrine 15 mg/kg twice daily from day 7 after infection. Eyes of the mice were observed with an operating microscope every other day. At day 14 after HSV inoculation, the corneas (n = 8) of each group were divided into inflamed and non-inflamed groups based on clinical observation, and harvested separately for cytokine mRNA analysis.
Cytokine mRNA expression mRNA extraction, cDNA synthesis and polymerase chain reaction (PCR) amplification were performed as previously described.17 Briefly, the corneas harvested on day 14 after infection were pooled by group, and put into RNAzol B solution (TEL-TEST, Friendswood, TX) that was maintained at 4°C, followed by homogenisation in the solution, extraction with phenol and chloroform, and precipitation with isopropanol. Total RNA (2.0 fLg) was used for synthesis of cDNA. Reverse transcription mix consisting of: 4 fLl 5X transcriptase buffer (Boehringer Mannheim, Indianapolis, IN), 2 fLl dNTPs (5 mM; Boehringer), 1 fLl oligo dt (18 mer), 0.5 fLl RNAse inhibitor (40 U / fLl; Promega) and 1.0 fLl of AMV reverse transcriptase (24 U / fLl; Boehringer) was added. The reverse transcription was allowed to proceed at 37°C for 60 min. cDNA samples were diluted 1/5 in distilled water and 20 fLl of this dilution was subjected to PCR amplification.
PCR amplification
The sense and anti-sense sequences of the oligonucleotide primers used, and the size of amplified PCR products (bp) for each pair of primers, are shown in Table 1 ; these sequences were chosen from published sequences in GenBank and synthesised on a Gene Semi-quantitative comparisons of mRNA content i)-Actin mRNA was amplified from each sample as quality control cDNA and also to adjust for differences in the amount of cellular RNA isolated during the RNA extraction; the l3-actin 'housekeeping' gene product was used to normalise the amount of RNA for every sample. Total RNA for cytokine testing was first semi-quantitated by PCR of i)-actin RNA and normalised to these amounts. After co-amplification of each cytokine's primers with i)-actin primers, the density of the bands from Southern blot films was analysed by scanning densitometry using a personal densitometer (Molecular Dynamics, Sunnydale, CA). The results of gene expression were determined by direct comparison of the ratios between both PCR products (cytokine and internal control). Using this method, we have been able to semi quantify mRNA levels and demonstrate kinetic behaviour in transcription of each sample at determined time points. IS We express the results (Table 2 ) on a zero to 4+ semi-quantitative scale.
Results
Clinical observation
HSK had developed in 70% of the untreated mice by 14 days after inoculation. The onset of keratitis was at days 8 to 10 after corneal infection, which was in accordance with our previous studies.I,2,16 No mice receiving acyclovir from day 0 developed HSK; the incidence of HSK was 10% in mice treated with tetrandrine from day 7. This result was in accordance with our previous observations.I6
Cytokine mRNA expression in corneas
Housekeeping gene glycerine-3'-phosphate dehydrogenase (GAPDH) mRNA was detected in every group of the corneas as expected. mRNA expression of all the cytokines studied was not found in normal
TNF-a. corneas. In the control group treated with distilled water, mRNA of IL-ll3, TNF-a, IL-6 and TGF-13 was expressed in the infected and inflamed corneas; intense IL-6 mRNA and relatively weaker TGF-13 mRNA was found as well in the infected but non-inflamed corneas. This result suggests that expression of IL-6 and TGF-13 mRNA in response to HSV infection is not, but that of IL-ll3 is, coincident with clinically obvious inflammatory destruction of the cornea. TNF-a mRNA expression was weakly detected in non-inflamed corneas of tetrandrine treated mice. IL-6 was found in the non-inflamed corneas of acyclovir-treated mice. Consistent TGF-13 mRNA expression was detected in all the infected corneas with and without inflammation of either treated or untreated mice. There was no significant difference between the groups of infected mice, and the expression of this cytokine in the infected cornea was not influenced by either tetrandrine or acyclovir (Fig. 1, Table 2 ).
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Discussion
It was reported that mRNA of T cell cytokines including IL-2, IL-4, IL-5, IL-lO and interferon gamma in mouse corneas was expressed and IL-lO may be involved in HSK resolution during the course of immunopathological herpetic stromal keratitis. 19 The present study demonstrates significant local gene expression of IL-ll3, IL-6, TNF-a and TGF-13 in response to HSV -1 infection in mouse cornea. Although cytokine protein production was not examined in this study, it is likely that the cytokine gene induction resulted in the actual release of cytokine proteins. The release of IL-1 and IL-6 together with TNF-a and TGF-13 may contribute both to the antiviral response to HSV-1 infection and to the corneal damage. The gene expression pattern of the cytokines suggests that they play distinct roles individually in the pathogenic process of HSK in mice. IL-1 and TNF-a are mainly produced by mononuclear leucocytes and are considered to be major mediators of the inflammatory processes.6,7,2 0 IL-1 and TNF-a are sometimes referred to as 'master' cytokines because of their ability to govern the expression of several other cytokines, including IL-6. Since IL-1(3 mRNA expression was only associated with, and was especially prominent in, the inflamed corneas, it appears that this cytokine is essentially required for induction of the corneal inflammation. IL-6 acts as a critical anti-inflammatory regulator in both local and systemic acute inflammatory responses by controlling the level of pro-inflammatory, but not anti inflammatory responses by controlling the level of pro inflammatory, but not anti-inflammatory cytokines.12 IL-6 also protects mice against experimental bacterial infectionI3 and against enterotoxin-induced toxic shock.1 4 A recent report indicates that IL-6 is not sufficient for inducing uveitis in mice,21 implying its possible regulatory role in the eye. Our results suggest that IL-6 and TGF-13 may function as anti-inflammatory mediators for protection against the virus-induced inflammation and for modulation of other proinflammatory cytokines in the cornea. The observation that an intense signal of IL-6 mRNA expression was obtained not only in the clinically inflamed corneas but also in the non-inflamed but infected corneas suggests that this cytokine can be produced by keratocytes and may be a beneficial regulator that suppresses inflammation and protects the cornea rather than an aggressive stimulator in the inflammatory process. This possibility was reinforced by the finding that expression of IL-6 was present in the non-inflamed corneas of acyclovir-treated mice. The results agree with the viewpoint that IL-6 functions as a pleiotropic immunoregulatory lymphokine and as an exocrine hormone in inflammation as indicated above?I-2 4 In addition, the observation that no or significantly reduced IL-6 mRNA expression in the uninflamed corneas of tetrandrine-or acyclovir-treated group was detected suggests that these two compounds may modulate local IL-6 mRNA expression.
TNF has been found to play a key role in orchestrating the complex events involved in inflammation and immunity. Most attention has been focused on the pro inflammatory actions of TNF-a. But TNF-a has also been reported to play a crucial role in the development of anterior-chamber-associated immune deviation (ACAID),25 suggesting its potential in the down regulation of infection in the eye. A recent study with TNF-a-deficient mice indeed indicates that this cytokine has an essential homeostatic role in limiting the extent and duration of an inflammatory process, i.e. an anti inflammatory function.11 Expression of TNF-a in the non-inflamed corneas treated with tetrandrine suggest that this cytokine, as well as IL-6, may play a role, or at least is not sufficient for induction of corneal inflammation. This dual function potential of TNF -pro inflammatory in the initial phase of infection and inflammation and anti-inflammatory after the infectious or toxic agent has been localised and controlled -has been noted previouslyY Such a dual function, presumably dose-dependent as well as phase-dependent, may occur in HSK.
We believe the suppressed expression of IL-ll3, IL-6 and TNF-a by acyclovir resulted from its effective inhibition of viral replication. Tetrandrine reportedly exhibits potent inhibitory effects of IL-1 and TNF-a release from monocytes?6,27 Despite the fact that we have shown consistent inhibition of HSV-mediated destructive keratitis by tetrandrine therapy, in this study we are unable to identify the effect of tetrandrine on IL-ll3 and TNF-a gene expression, since there was no expression of either cytokine in the uninflamed corneas of the untreated mice. However, our finding demonstrated clearly that tetrandrine inhibited mRNA expression of IL-6 in the cornea. It is interesting to note that TGF-13 mRNA was consistently expressed in response to the infection and was not changed in the inflamed and uninflamed corneas, 'and even not influenced by either of the compounds used in this study. The detailed mechanisms of tetrandrine inhibition of destructive keratopathy in murine HSK remain to be elucidated.
Investigations with cytokine-gene-deficient mice are under way to further investigate the role of these and other cytokines in the pathogenesis of HSK, and the mechanism of action of tetrandrine.
We fully recognise that this is a preliminary study of a limited cytokine panel with semi-quantitative PCR. We are currently in the process of examining our expanded panel of cytokines in the model with internally nested controls in a quantitative PCR technique. However, we think that sharing the preliminary results of the effects of an interesting, novel immunomodulator (tetrandrine) with the vision research community is of substantial interest.
